Document and Entity Information Document Type Document Quarterly Report Document Period End Date Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag CONDENSED CONSOLIDATED BALANCE SHEETS Assets [Abstract] ASSETS Assets, Current [Abstract] Current assets Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Accounts receivable, net Accounts receivable, net Inventory, Net. Inventory Total inventory Prepaid Expense and Other Assets, Current Prepaid expenses Other Assets, Current Other current assets Assets, Current Total current assets Property, Plant and Equipment, Net Property and equipment, net Total property and equipment, net Operating Lease, Right-of-Use Asset Operating lease right-of-use assets Other Assets, Noncurrent Other assets Assets Total assets Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities, Current [Abstract] Current liabilities Accounts Payable, Current Accounts payable Accrued Liabilities, Current Accrued expenses Total accrued expenses Due to Related Parties, Current Due to related parties Interest Payable, Current Accrued interest Other Liabilities, Current Other current liabilities Liabilities, Current Total current liabilities Operating Lease, Liability, Noncurrent Long-term portion of operating lease liabilities Long-term portion operating lease liability Derivative Liability, Noncurrent Derivative liabilities Long-Term Debt, Excluding Current Maturities Long-term debt Long-term debt, net Liabilities Total liabilities Commitments and Contingencies. Commitments and contingencies (Note 15) Stockholders' Equity Attributable to Parent [Abstract] Stockholders' equity Preferred Stock, Value, Issued Preferred stock, $0.001 par value, 10,000 shares authorized; no shares issued and outstanding as of June 30, 2023 and December 31, 2022 Common Stock, Value, Issued Common stock, $0.001 par value, 100,000 shares authorized as of June 30, 2023 and December 31, 2022; 29,267 and 28,147 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively Additional Paid in Capital. Additional paid-in-capital Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders' Equity Attributable to Parent Ending Balance Beginning Balance Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Preferred Stock, Par or Stated Value Per Share Preferred stock, par value (in dollars per share) Preferred Stock, Shares Authorized Preferred stock, shares authorized (in shares) Preferred Stock, Shares Issued Preferred stock, shares issued (in shares) Preferred Stock, Shares Outstanding Preferred stock, shares outstanding (in shares) Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized (in shares) Common Stock, Shares, Issued Common stock, shares issued (in shares) Common Stock, Shares, Outstanding Ending Balance (in shares) Beginning Balance (in shares) Common stock, shares outstanding (in shares) CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Revenue from Contract with Customer, Excluding Assessed Tax Product revenue, net Costs and Expenses [Abstract] Operating expenses Cost of Goods and Services Sold Cost of goods sold Research and Development Expense. Research and development Selling, General and Administrative Expense Selling, general and administrative Costs and Expenses Total operating expenses Operating Income (Loss) Loss from operations Interest Expense [Abstract] Other expense (income) Interest Expense Interest expense Total interest expense Interest income Interest income Other Nonoperating Income (Expense) Other income, net Net Income (Loss) Attributable to Parent Net loss Net loss Net loss (numerator) Earnings Per Share, Basic Basic net loss per share attributable to common stockholders (in dollars per share) Basic net loss per share (in dollars) Earnings Per Share, Diluted Diluted net loss per share attributable to common stockholders (in dollars per share) Diluted net loss per share (in dollars) Weighted Average Number of Shares Outstanding, Basic Weighted average shares (denominator) - basic Weighted average shares outstanding - basic Weighted Average Number of Shares Outstanding, Diluted Weighted average shares outstanding - diluted Weighted average shares (denominator) - diluted CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Statement [Table] Equity Components [Axis] Equity Component [Domain] Common stock Additional Paid in Capital Accumulated Deficit Statement [Line Items] Stock Issued During Period, Value, New Issues Issuance of common shares, net of offering costs Stock Issued During Period, Shares, New Issues Number of shares issued Issuance of common shares, net of offering costs (in shares) APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Stock-based compensation Adjustments to Additional Paid in Capital, Warrant Issued Issuance of stock purchase warrants Stock Issued During Period, Value, Stock Options Exercised Exercise of stock options Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Options exercised (in shares) Exercise of stock options (in shares) Restricted Stock, Value, Shares Issued Net of Tax Withholdings Vesting of restricted stock units, net of employee tax obligations Restricted Stock, Shares Issued Net of Shares for Tax Withholdings Vesting of restricted stock units, net of employee tax obligations (in shares) CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities [Abstract] OPERATING CASH FLOW ACTIVITIES: Net Income (Loss) Attributable to Parent. Net loss Reconciliation of net loss to net cash (used in) provided by operating activities: Reconciliation of net loss to net cash used in operating activities Depreciation Depreciation Amortization of Debt Issuance Costs and Discounts Accretion of debt discount and amortization of financing costs Change in Fair Value of Derivative Liabilities Change in fair value of derivative liabilities Share-based Compensation Stock-based compensation expense Paid-in-Kind Interest Payable-in-kind interest on Credit Agreement Gain (Loss) on Disposition of Property Plant Equipment Loss on disposal of equipment Amount of increase decrease in operating lease right of use assets. Increase Decrease In Operating Lease Right of Use Assets Operating lease right-of-use assets Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities Increase (Decrease) in Accounts and Other Receivables Accounts receivable Increase (Decrease) in Inventories Inventory Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses, other current assets and other assets Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Accounts payable, accrued expenses, due to related parties, and other current liabilities Increase (Decrease) in Interest Payable, Net Accrued interest Increase (Decrease) in Operating Lease Liability Operating lease liabilities Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] INVESTING CASH FLOW ACTIVITIES: Payments to Acquire Property, Plant, and Equipment Purchases of equipment and leasehold improvements Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] FINANCING CASH FLOW ACTIVITIES: Proceeds from Issuance of Long-Term Debt Proceeds from long-term debt Payments of Debt Issuance Costs Debt issuance costs Proceeds from Issuance of Common Stock Proceeds from issuance of common stock Payments of Stock Issuance Costs Offering costs for common stock issuance Stock offering costs Payment, Tax Withholding, Share-Based Payment Arrangement Payment of employee tax obligations related to vested restricted stock units Proceeds from Stock Options Exercised Exercise of stock options Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net (decrease) increase in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and cash equivalents, end of the period Cash and cash equivalents, beginning of the period Supplemental Disclosures of Cash Flow Information Supplemental cash flow information: The amount of stock issuance costs that were incurred during a noncash or partial noncash transaction. Stock Issuance Costs Incurred During Noncash or Partial Noncash Transaction Deferred initial public offering costs in accounts payable No definition available. Nature of the Business Nature of Operations [Text Block] Nature of the Business Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Basis of Presentation Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Inventory Inventory Disclosure [Text Block] Inventory Property and Equipment, Net Property, Plant and Equipment Disclosure [Text Block] Property and Equipment, Net Accrued Expenses Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Accrued Expenses Transactions with BioXcel LLC Related Party Transactions Disclosure [Text Block] Transactions with BioXcel LLC Debt and Credit Facilities Debt Disclosure [Text Block] Debt and Credit Facilities Derivative Financial Instruments Derivative Instruments and Hedging Activities Disclosure [Text Block] Derivative Financial Instruments n/a Common Stock Financing Activities The entire disclosure for Financing Activities. Financing Activities Disclosure [Text Block] Common Stock Financing Activities Stock-Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock-Based Compensation Leases Lessee, Operating Leases [Text Block] Leases Fair Value Measurements Fair Value Disclosures [Text Block] Fair Value Measurements Net Loss Per Share Earnings Per Share [Text Block] Net Loss Per Share Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Subsequent Events Subsequent Events [Text Block] Subsequent Events Use of Estimates, Policy [Policy Text Block] Use of Estimates Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Accounts Receivable [Policy Text Block] Accounts Receivable, Net Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentrations of Credit Risk Inventory, Policy [Policy Text Block] Inventory Disclosure of accounting policy for deferred offering costs. Deferred Offering Costs [Policy Text Block] Deferred Initial Public Offering Costs Property, Plant and Equipment, Policy [Policy Text Block] Property and Equipment Lessee, Leases [Policy Text Block] Leases Debt, Policy [Policy Text Block] Debt and Detachable Warrants Derivatives, Policy [Policy Text Block] Derivative Assets and Liabilities Revenue Recognition Accounting Policy, Gross and Net Revenue Disclosure [Policy Text Block] Revenue Recognition Cost of Goods and Service [Policy Text Block] Cost of Goods Sold Compensation Related Costs, Policy [Policy Text Block] Stock-Based Compensation Research and Development Expense, Policy [Policy Text Block] Research and Development Costs Disclosure of accounting policy for patent costs. Patent Costs [Policy Text Block] Patent Costs Fair Value Measurement, Policy [Policy Text Block] Fair Value of Financial Instruments Earnings Per Share, Policy [Policy Text Block] Earnings (Loss) Per Share Segment Reporting, Policy [Policy Text Block] Segment Information New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Tabular disclosure of Property Plant And Equipment Useful Lives. Schedule of Property Plant And Equipment Useful Lives [Table Text Block] Schedule of Property Plant and Equipment useful lives Schedule of Inventory, Current [Table Text Block] Schedule of inventory Property, Plant and Equipment [Table Text Block] Schedule of Property and Equipment, net Schedule of Accrued Liabilities [Table Text Block] Schedule of accrued expenses Schedule of Related Party Transactions [Table Text Block] Schedule of service charges Schedule of Long-Term Debt Instruments [Table Text Block] Schedule of debt Schedule of Maturities of Long-Term Debt [Table Text Block] Schedule of maturities on long-term debt Tabular disclosure of interest expense associated with long-term debt. Schedule of Interest Expense Associated with Long Term Debt [Table Text Block] Schedule of long-term debt interest expense Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Equity Award [Domain] BTI RSU Share instrument associated with OnkosXcel, which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met. OnkosXcel RSUs Represents the information pertaining to OnkosXcel time based profit-sharing units OnkosXcel PSUs Stock options Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Stock-Based Compensation Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Schedule of activity relating to RSUs Share-Based Compensation Arrangements by Share-Based Payment Award, Performance-Based Units, Vested and Expected to Vest [Table Text Block] Schedule of activity relating to PSUs Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of Stock Option Activity Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Valuation Assumptions Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of stock-based compensation charges Lessee, Operating Lease, Liability, Maturity [Table Text Block] Summary of maturities of the operating lease liability Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of fair value on a recurring basis Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of changes in Level 3 liabilities Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Schedule of fair value unobservable inputs Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of net loss per share Property, Plant and Equipment [Table] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Equipment Furniture Range [Axis] Range [Domain] Minimum Maximum Property, Plant and Equipment [Line Items] Summary of Significant Accounting Policies Equipment Property, Plant and Equipment, Useful Life Useful life Number of Operating Segments Number of segments Deferred Offering Costs. Deferred offering costs Inventory, Raw Materials, Gross Raw materials Inventory, Work in Process, Gross Work-in-process Inventory, Finished Goods, Gross Finished goods Inventory Valuation Reserves Inventory write-downs Computers and equipment Leasehold improvements Property, Plant and Equipment, Gross Total property and equipment, gross Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accumulated depreciation The amount of accrued research and development expenses. Accrued Research And Development Expenses Accrued research and development expenses Employee-related Liabilities, Current Accrued compensation and benefits Accrued Professional Fees, Current Accrued professional fees Taxes Payable, Current Accrued taxes Other Accrued Liabilities, Current Other accrued expenses Schedule of Related Party Transactions, by Related Party [Table] Counterparty Name [Axis] Counterparty Name [Domain] Represents BioXcel LLC. BioXcel LLC Income Statement Location [Axis] Income Statement Location [Domain] Research and development Selling, general and administrative Related Party Transaction [Line Items] Transactions with BioXcel Related Party Transaction, Expenses from Transactions with Related Party Service charges Schedule of Long-term Debt Instruments [Table] Debt Instrument [Axis] Debt Instrument, Name [Domain] Represents OFA as debt administrative agent. OFA Information related to financing agreements. Credit Facility Information related to the Senior Secured Term Loan agreement. Credit Agreement and Guaranty Credit Agreement and Guaranty Information related to the Revenue Interest Financing agreement Revenue interest financing Revenue Interest Financing Agreement Debt Instrument [Line Items] Debt Debt Instrument, Face Amount Face amount borrowed Revenue Interest Financing Agreement Debt Instrument, Increase, Accrued Interest Accrued interest Repayments of Debt Payments Long-Term Debt, Gross Long-term debt, gross Amount before unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation. Long Term Debt, Before Unamortized (Discount) Premium and Debt Issuance Costs, Non-Current Long-term debt liability Debt, Current Debt classified as current Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Unamortized debt discounts and issuance costs Line of Credit Facility, Maximum Borrowing Capacity Maximum borrowing capacity Line of Credit Facility [Table] Scenario [Axis] Scenario, Unspecified [Domain] Represents information pertaining to Tranche A. Tranche A Represents information pertaining to Tranche B. Tranche B Represents information pertaining to Tranche C. Tranche C It pertains to date from effective Date until the date on which the second tranche of loans are funded. Step Up Date It pertains to date from and after the Step-Up Date. After Step Up Date Line of Credit Facility [Line Items] Debt Line of Credit Facility, Remaining Borrowing Capacity Remaining borrowing capacity Percentage of basis point original issue discount at which the borrowings under the credit agreement are issued. Debt Instrument Interest Rate, Discount Rate Percentage Discount rate (as a percent) Debt Instrument, Interest Rate, Stated Percentage Debt stated interest (as a percent) Paid-in-kind interest rate for funds borrowed, under the debt agreement. Paid-in-Kind Interest, Percentage Debt paid-in-kind interest (as a percent) Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Commitment fee (as a percent) Minimum maintenance of cash or permitted cash equivalent investments in accounts controlled by lenders. Net Cash Required, Minimum Cash maintenance in controlled accounts It is additional increase in the minimum maintenance of cash or permitted cash equivalent investments in accounts controlled by OFA for the Lenders. Additional Restricted Cash Additional cash to maintained The percentage of ownership of common stock of subsidiary. Subsidiary Ownership, Percentage Subsidiary ownership (as a percent) Percentage of outstanding Loan. Percentage of Outstanding Loan Outstanding loan (as a percent) Maximum payment required per debt agreement if failure to satisfy the Revenue Covenant. Revenue Covenant Noncompliance Penalty Revenue covenant noncompliance payment Threshold actual revenue during the revenue covenant measurement period Credit Agreement, Threshold Actual Revenue During Revenue Covenant Measurement Period Represents information pertaining to Tranche B and Trance C Tranche B and C Debt Instrument, Interest Rate, Effective Percentage Effective interest rate (as a percent) Represents the maximum borrowings allowed based on a percentage of net sales. Borrowings Based on Net Sales, Percent Borrowing allowed per net sales (as a percent) Represents threshold ratio for debt to revenue ratio. Threshold Ratio of Debt to Revenue Ratio Debt to revenue multiplier Debt to purchasers invested capital multiplier in next twelve months. Threshold Ratio of Debt to Purchasers Invested Capital Ratio, Year One Purchasers invested capital multiplier in year one Debt to purchasers invested capital multiplier in two years. Threshold Ratio of Debt to Purchasers Invested Capital Ratio, Year Two Purchasers invested capital multiplier in year two Debt to purchasers invested capital multiplier in three years. Threshold Ratio of Debt to Purchasers Invested Capital Ratio, Year Three Purchasers invested capital multiplier in year three Debt to purchasers invested capital multiplier in four years and thereafter. Threshold Ratio of Debt to Purchasers Invested Capital Ratio, Year Four and Thereafter Purchasers invested capital multiplier in four years and thereafter Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Information related to the Oaktree (OFA) Warrants. BTI Warrants Represents the information pertaining to OnkosXcel. OnkosXcel Warrants Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrants to purchase common stock (in shares) Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price (in dollars per share) Maximum equity investment allowed for lenders in entity's common stock. Right to Purchase Stock, Lenders Maximum equity investment allowed for lenders Represents premium percentage for share price determined over a specified period of time. Premium Share Price, Percent Premium share price (as a percent) Threshold amount of liquidity event for exercise of warrants. Threshold Liquidity Event Amount for Exercise of Warrants Threshold amount of liquidity event for exercise of warrants Percentage of fair value of consideration to be paid. Percentage of Fair Value Consideration to Be Paid Percentage of fair value of consideration to be paid Percentage of valuation applicable to initial profits. Percentage of Valuation Applicable to Initial Profits Percentage of valuation applicable to initial profits Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Common stock issuable (in shares) Long-Term Debt, Maturity, Remainder of Fiscal Year 2023 Long-Term Debt, Maturity, Year One 2024 Long-Term Debt, Maturity, Year Two 2025 Long-Term Debt, Maturity, Year Three 2026 Long-Term Debt, Maturity, Year Four 2027 Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Long Term Debt Maturities Repayments Of Principal After Year Four Thereafter Interest Expense, Debt Interest expense Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Sale of Stock [Axis] Sale of Stock [Domain] Represents information pertaining to Jefferies LLC. Jefferies Sale Agreement Subsidiary, Sale of Stock [Line Items] Shares issued Share Price Purchase price (in dollar per share) Fair value of grants per share Plan Name [Axis] Plan Name [Domain] Represents information pertaining to 2020 Incentive Award Plan. 2020 Incentive Award Plan Information related to the 2017 Stock Plan. 2017 Equity Incentive Plan Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Authorized shares Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Available for grant (in shares) Represents the percentage of aggregate number of shares of common stock outstanding of the immediately preceding calendar year as a increase to common stock available for grant under the plan. Share-based Compensation Arrangement by Share-based Payment Award, Percentage Of Increase In Common Stock Available For Grant Annual increase in shares available for grant (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Increase in shares available for issuance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Terms of award Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Vesting period Award Date [Axis] Award Date [Domain] Award granted under share-based payment arrangement during 2023. Grant Date 2023 Award granted under share-based payment arrangement during 2022. Grant Date 2022 Grantee Status [Axis] Grantee Status [Domain] Employee Nonemployee consultant Executive officers Vesting [Axis] Vesting [Domain] Tranche One Tranche Two Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Number of shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Outstanding, ending balance (in shares) Outstanding, beginning balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Vested aggregate (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Weighted average price Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted average price (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Weighted average price, aggregate vested (in dollars per share) Period over which grantee's right to exercise award under share-based payment arrangement is allowed after initial public offering. Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period After Initial Public Offering Vesting period after IPO Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Vesting (as a percent) Allocated Share-based Compensation Expense Share-based compensation costs recognized Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Unrecognized stock-based compensation expense Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average fair value of non-options granted (in dollars per share) Weighted-average grant-date fair value of options granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Outstanding, ending balance (in shares) Outstanding, beginning balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Options granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Options forfeited (in shares) The number of shares under options that were cancelled during the reporting period. Share-based Compensation Arrangement by Share-based Payment Award, Options, Cancelled in Period Options cancelled (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Options vested and exercisable (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price per Share Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Outstanding, end balance (in dollars per shares) Outstanding, beginning balance (in dollars per shares) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Options granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Options forfeited (in dollars per shares) Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were cancelled. Share-based Compensation Arrangements by Share-based Payment Award, Options, Cancelled in Period, Weighted Average Exercise Price Options cancelled (in dollars per shares) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Options exercised (in dollars per shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Options vested and exercisable (in dollars per shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Intrinsic value, outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Intrinsic value, exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Intrinsic value, exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value Weighted-average grant-date fair value of options vested (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Weighted average remaining contractual life, exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted average remaining contractual life, outstanding Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected term Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected stock price volatility (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Expected stock price volatility, minimum (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Expected stock price volatility, maximum (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free rate of interest (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Risk-free rate of interest, minimum (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Risk-free rate of interest, maximum (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend yield (as a percent) Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Unrecognized compensation expense Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Remaining unamortized expense period Schedule of Employee Stock Ownership Plan (ESOP) Disclosures [Table] Represents information pertaining to the 2020 Employee Stock Purchase Plan. 2020 Employee Stock Purchase Plan Employee Stock Ownership Plan (ESOP) Disclosures [Line Items] Employee Stock Purchase Plan Represents the maximum number of shares issued or transferred under ESPP. Employee Stock Purchase Plan, Maximum Number Of Shares Issued Or Transferred Maximum number of shares issued or transferred under ESPP Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent Purchase price as a percent of fair market value Stock Issued During Period, Shares, Employee Stock Purchase Plans Shares issued under ESPP Operating Lease Liabilities, Payments Due [Abstract] Maturities of the operating lease liability Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year Remainder of 2023 Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months 2024 Lessee, Operating Lease, Liability, Payments, Due Year Two 2025 Lessee, Operating Lease, Liability, Payments, Due Year Three 2026 Lessee, Operating Lease, Liability, Payments, Due Total lease payments Lessee, Operating Lease, Liability, Undiscounted Excess Amount Imputed interest Operating Lease, Liability Total lease liability Operating Lease, Liability, Current Less current portion of lease liability Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Operating Lease, Expense Lease expense Lessee, Operating Lease, Existence of Option to Extend [true false] Option to renew the lease Lessee, Operating Lease, Renewal Term Renewal term Fair Value, Recurring and Nonrecurring [Table] Measurement Frequency [Axis] Measurement Frequency [Domain] Recurring Measurement Basis [Axis] Portion at Fair Value Measurement [Member] Fair Value Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Level 1 Level 3 Information related to the Equity Investment agreement. Equity Investment Rights Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair value assets and liabilities Cash and Cash Equivalents, Fair Value Disclosure Fair value money market accounts Derivative Liability Derivative liabilities Derivative Liability, Statement of Financial Position [Extensible Enumeration] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Level 3 reconciliation Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Level 3 liabilities reconciliation Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Ending balance Beginning balance Liabilities, Fair Value Adjustment Change in fair value Fair Value Measurement Inputs and Valuation Techniques [Table] Measurement Input Type [Axis] Measurement Input Type [Domain] Strike price Volatility (annual) Measurement input using rate at which there is a probability of exercise. Probability of exercise Risk-free rate Time period (years) Measurement input using estimated premium. Measurement Input, Estimated Premium [Member] Estimated premium to 30-day average Discount rate Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair value inputs Derivative Liability, Measurement Input Derivative liability input Debt Instrument, Fair Value Disclosure Fair value debt Warrants Not Settleable in Cash, Fair Value Disclosure Fair value warrant classified as equity Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Common stock equivalents outstanding Other Commitments [Table] Other Commitments [Line Items] Commitments and Contingencies Supply Commitment, Remaining Minimum Amount Committed Minimum annual payments Period covered by the agreement commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Agreement Commitment, Period Commitment agreement period Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Subsequent Event [Line Items] Subsequent Events The number of positions expected to be eliminated as a percentage of total positions in connection with the restructuring plan(s). Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent Expected employees eliminated (as a percent) Effect on Future Earnings, Amount Operating expenses reduction Restructuring and Related Cost, Expected Cost Remaining Estimated restructuring costs